Peter R Kowey Selected Research

Dronedarone

6/2023	Dronedarone versus sotalol in patients with atrial fibrillation: A systematic literature review and network meta-analysis.
1/2022	Impact of dronedarone on patients with atrial fibrillation and diabetes: A sub-analysis of the ATHENA and EURIDIS/ADONIS studies.
1/2022	Predictors of dronedarone plasma drug concentrations and effect on atrial fibrillation/atrial flutter recurrence: Analyses from the EURIDIS and ADONIS studies.
1/2022	AIM-AF: A Physician Survey in the United States and Europe.
3/2020	Efficacy and safety of dronedarone in patients with a prior ablation for atrial fibrillation/flutter: Insights from the ATHENA study.
1/2020	Dronedarone treatment following cardioversion in patients with atrial fibrillation/flutter: A post hoc analysis of the EURIDIS and ADONIS trials.
12/2014	Efficacy and safety of dronedarone in patients previously treated with other antiarrhythmic agents.
11/2014	The role of dronedarone in the treatment of atrial fibrillation/flutter in the aftermath of PALLAS.
8/2009	Dronedarone.
11/2008	Dronedarone: a new treatment for atrial fibrillation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter R Kowey Research Topics

Disease

91	Atrial Fibrillation 03/2024 - 09/2004
33	Stroke (Strokes) 01/2023 - 03/2005
23	Hemorrhage 01/2021 - 02/2012
19	Heart Failure 11/2023 - 02/2003
12	Atrial Flutter (Flutter, Atrial) 01/2023 - 08/2009
11	Myocardial Infarction 01/2023 - 09/2004
10	Cardiac Arrhythmias (Arrythmia) 01/2022 - 06/2005
9	Ventricular Tachycardia 01/2023 - 09/2002
6	Ventricular Fibrillation 10/2020 - 08/2004
6	Hypertension (High Blood Pressure) 01/2020 - 12/2005
6	Torsades de Pointes (Torsade de Pointes) 01/2016 - 02/2003
5	Embolism (Embolus) 01/2019 - 12/2015
5	Hypotension (Low Blood Pressure) 12/2009 - 03/2005
4	Bradycardia 11/2023 - 03/2005
4	Frailty 01/2019 - 07/2013
4	Inflammation (Inflammations) 04/2016 - 01/2008
3	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2023 - 07/2008
3	Chronic Renal Insufficiency 09/2021 - 01/2018
3	Diabetes Mellitus 01/2020 - 12/2005
3	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2019 - 09/2006
3	Thrombosis (Thrombus) 01/2018 - 03/2014
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2017 - 09/2013
3	Thromboembolism 02/2012 - 09/2004
3	Heart Diseases (Heart Disease) 03/2010 - 03/2005
3	Ischemia 12/2005 - 09/2002
2	Cough 03/2024 - 01/2022
2	Pain (Aches) 03/2024 - 01/2022
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 07/2013
2	Hyperlipidemias (Hyperlipidemia) 01/2020 - 07/2013
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 11/2013
2	Shock 01/2019 - 04/2011
2	Tachycardia (Tachyarrhythmias) 01/2019 - 01/2016
2	Transient Ischemic Attack 01/2018 - 05/2015
2	Neoplasms (Cancer) 01/2017 - 01/2013
2	Peripheral Vascular Diseases (Peripheral Vascular Disease) 07/2013 - 12/2005
2	Left Ventricular Dysfunction 01/2013 - 06/2005
2	Sudden Death 12/2011 - 06/2005
2	Type 2 Diabetes Mellitus (MODY) 12/2005 - 03/2005
2	Premature Cardiac Complexes (Extrasystoles) 08/2005 - 08/2004
1	Syncope (Fainting) 11/2023
1	Unstable Angina 01/2023
1	Rhinorrhea 01/2023
1	Constipation 01/2023
1	Supraventricular Tachycardia 01/2023
1	Polymorphic catecholergic ventricular tachycardia 01/2022
1	Critical Illness (Critically Ill) 01/2020

Drug/Important Bio-Agent (IBA)

24	Anti-Arrhythmia AgentsIBA 11/2023 - 09/2005
21	AnticoagulantsIBA 09/2021 - 04/2010
18	Warfarin (Coumadin)FDA LinkGeneric 10/2020 - 04/2010
12	Amiodarone (Amiodarona)FDA LinkGeneric 01/2020 - 09/2002
11	Dronedarone FDA Link 06/2023 - 09/2007
8	Vitamin K FDA Link 01/2021 - 03/2014
6	N(4)-oleylcytosine arabinosideIBA 01/2021 - 12/2016
4	CreatinineIBA 09/2021 - 12/2005
4	RivaroxabanIBA 01/2021 - 12/2015
4	Dabigatran FDA Link 11/2018 - 11/2013
3	Sotalol (Sotalol Hydrochloride)FDA LinkGeneric 06/2023 - 04/2011
3	dofetilide (Tikosyn)FDA Link 01/2022 - 08/2002
3	Factor Xa InhibitorsIBA 01/2020 - 12/2014
3	azimilideIBA 03/2017 - 08/2005
3	celivaroneIBA 05/2012 - 12/2011
3	Polysorbates (PSML)FDA Link 10/2009 - 04/2009
3	Benzyl Alcohol (Benzenemethanol)FDA Link 10/2009 - 04/2009
2	SolutionsIBA 03/2024 - 01/2022
2	Flecainide (Tambocor)FDA LinkGeneric 03/2024 - 01/2022
2	etripamilIBA 11/2023 - 01/2023
2	Nasal SpraysIBA 11/2023 - 01/2023
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2023 - 09/2015
2	PotassiumIBA 01/2022 - 08/2004
2	omega-Chloroacetophenone (Mace)IBA 01/2019 - 09/2013
2	Mineralocorticoid Receptor AntagonistsIBA 01/2018 - 11/2005
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2017 - 04/2010
2	vanoxerine (I 893)IBA 01/2016 - 06/2015
2	Mexiletine (Mexitil)FDA LinkGeneric 08/2015 - 06/2015
2	SodiumIBA 08/2015 - 05/2010
2	CalciumIBA 07/2008 - 12/2005
2	Antihypertensive Agents (Antihypertensives)IBA 12/2005 - 03/2005
2	Losartan (Cozaar)FDA LinkGeneric 12/2005 - 03/2005
2	Carvedilol (Coreg)FDA LinkGeneric 11/2005 - 06/2005
1	Type A Botulinum Toxins (Botox)FDA Link 03/2024
1	Serotonin (5 Hydroxytryptamine)IBA 01/2023
1	eicosapentaenoic acid ethyl esterIBA 01/2023
1	prucaloprideIBA 01/2023
1	SaccharinIBA 01/2022
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2022
1	Lidocaine (Xylocaine)FDA LinkGeneric 10/2020
1	bretyliumIBA 10/2020
1	SDMIBA 10/2020
1	antineoplaston A10 (A 10)IBA 10/2020
1	bivalirudin (Angiomax)FDA Link 01/2020

Therapy/Procedure

48	Therapeutics 11/2023 - 02/2003
12	Electric Countershock (Cardioversion) 03/2024 - 05/2004
8	Catheter Ablation 03/2020 - 12/2009
4	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2019 - 09/2006
3	Percutaneous Coronary Intervention 01/2020 - 12/2005
3	Drug Therapy (Chemotherapy) 01/2018 - 01/2008
2	Drug Tapering 01/2020 - 01/2018
2	Secondary Prevention 01/2019 - 07/2013
1	Injections 03/2024
1	Nebulizers and Vaporizers (Inhaler) 01/2022